We are live on
!
Find out more
CM
Crestline Management Portfolio holdings
AUM
$46.3M
1-Year Est. Return
48.82%
This Fund
S&P 500
This Quarter
Est. Return
+21.79%
1 Year Est. Return
+48.82%
3 Year Est. Return
+52.52%
5 Year Est. Return
+37.91%
10 Year Est. Return
+316.44%
AUM
$1.16B
AUM Growth
+$372M
(+47%)
Cap. Flow
+$132M
Cap. Flow
% of AUM
11.39%
Top 10 Holdings %
Top 10 Hldgs %
68.38%
Holding
232
New
129
Increased
24
Reduced
12
Closed
56
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sana Biotechnology
SANA
|
+$72.8M |
| 2 |
Petrobras Class A
PBR.A
|
+$20.9M |
| 3 |
Ameriprise Financial
AMP
|
+$11.4M |
| 4 |
MetLife
MET
|
+$10.1M |
| 5 |
Wells Fargo
WFC
|
+$7.59M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Denali Therapeutics
DNLI
|
+$114M |
| 2 |
Micron Technology
MU
|
+$7.77M |
| 3 |
UDR
UDR
|
+$5.92M |
| 4 |
Equitable Holdings
EQH
|
+$4.95M |
| 5 |
Lam Research
LRCX
|
+$4.46M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 61.94% |
| 2 | Financials | 15.05% |
| 3 | Materials | 5.33% |
| 4 | Technology | 3.84% |
| 5 | Energy | 2.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Rambus
RMBS
$9.87B
| $3.24M | 0.28% |
+136,603
| New | +$2.75M |
|
52
Teradyne
TER
$57.6B
| $3.21M | 0.28% |
+24,000
| New | +$3.07M |
|
|
BERY
53
DELISTED
Berry Global Group, Inc.
BERY
| $3.17M | 0.27% |
+52,925
| New | +$3.18M |
|
54
Silicon Motion
SIMO
$8.6B
| $3.16M | 0.27% |
49,244
-28,800
| -37% | -$1.89M |
|
55
Capital One
COF
$128B
| $3.09M | 0.27% |
+20,000
| New | +$3.02M |
|
56
Cboe Global Markets
CBOE
$32.5B
| $2.98M | 0.26% |
+25,000
| New | +$2.74M |
|
57
Hillman Solutions
HLMN
$1.54B
| $2.96M | 0.25% |
+238,400
| New | +$2.66M |
|
|
GRSV
58
DELISTED
Gores Holdings V, Inc.
GRSV
| $2.96M | 0.25% |
+292,700
| New | +$2.99M |
|
|
CMA
59
DELISTED
Comerica
CMA
| $2.85M | 0.25% |
+40,000
| New | +$2.96M |
|
60
XPO
XPO
$23.6B
| $2.73M | 0.24% |
+56,527
| New | +$2.76M |
|
61
GSK
GSK
$104B
| $2.64M | 0.23% |
+53,081
| New | +$2.55M |
|
62
Graphic Packaging
GPK
$3.17B
| $2.63M | 0.23% |
+144,800
| New | +$2.65M |
|
63
Huntsman Corp
HUN
$1.71B
| $2.62M | 0.23% |
+98,850
| New | +$2.81M |
|
64
DuPont de Nemours
DD
$18.5B
| $2.61M | 0.23% |
+26,856
| New | +$2.7M |
|
|
SF
65
Stifel
SF
$12.6B
| $2.59M | 0.22% |
+60,000
| New | +$2.69M |
|
|
LEGO
66
DELISTED
Legato Merger Corp. Common stock
LEGO
| $2.54M | 0.22% |
253,100
+227,300
| +881% | +$2.24M |
|
67
Teck Resources
TECK
$29.6B
| $2.49M | 0.21% |
+108,000
| New | +$2.46M |
|
68
Expedia Group
EXPE
$35.4B
| $2.41M | 0.21% |
+14,700
| New | +$2.52M |
|
|
CVA
69
DELISTED
Covanta Holding Corporation
CVA
| $2.37M | 0.2% |
+134,300
| New | +$2.04M |
|
70
Hanover Insurance
THG
$8.1B
| $2.3M | 0.2% |
+16,965
| New | +$2.33M |
|
71
Cirrus Logic
CRUS
$6.53B
| $2.23M | 0.19% |
+26,258
| New | +$2.11M |
|
72
Qorvo
QRVO
$7.99B
| $2.15M | 0.19% |
+11,000
| New | +$2.03M |
|
73
United Therapeutics
UTHR
$25.8B
| $2.02M | 0.17% |
+11,255
| New | +$2.14M |
|
|
WRK
74
DELISTED
WestRock Company
WRK
| $1.9M | 0.16% |
+35,700
| New | +$2M |
|
75
United Rentals
URI
$67.2B
| $1.84M | 0.16% |
+5,783
| New | +$1.87M |
|
Similar funds
MCMC
RRC
PCM
NPCM
FCM
EGI
IPHI
SM
Crestline Management's Q2 2021 Portfolio in Review
As of Q2 2021, Crestline Management held 232 positions worth $1.16B, up 47% from $788M the previous quarter. Its ten largest holdings account for 68% of the portfolio.
Crestline Management deployed $132M of net new capital in Q2 2021, opening 129 new positions and adding to 24 existing holdings. Its largest new stake was Sana Biotechnology: 3,210,937 shares worth $63.1M.
By sector, the portfolio is most concentrated in Healthcare at 62% of assets, down from 72% a quarter earlier, followed by Financials and Materials.
On the sell side, the largest reduction was Denali Therapeutics, an estimated $114M trimmed.
- Crestline Management's largest Q2 2021 buy was Sana Biotechnology: 3,210,937 shares worth $63.1M.
- Crestline Management added most to Travelers Companies in Q2 2021, an estimated $6.82M increase.
- Crestline Management's biggest Q2 2021 reduction was Denali Therapeutics, cutting an estimated $114M.
- Crestline Management fully exited Micron Technology in Q2 2021, selling an estimated $7.77M.
- Crestline Management's ten largest holdings make up 68% of its $1.16B portfolio in Q2 2021.
- Crestline Management opened 129 new positions and closed 56 in Q2 2021.
- Crestline Management's portfolio value rose 47% quarter-over-quarter to $1.16B.
Based on Crestline Management's 13F filing for Q2 2021, filed 13 Aug 2021.